HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mark Lubberink Selected Research

ABY-025

3/2020Kinetic analysis of HER2-binding ABY-025 Affibody molecule using dynamic PET in patients with metastatic breast cancer.
1/2016Measuring HER2-Receptor Expression In Metastatic Breast Cancer Using [68Ga]ABY-025 Affibody PET/CT.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mark Lubberink Research Topics

Disease

27Neoplasms (Cancer)
11/2021 - 02/2002
12Alzheimer Disease (Alzheimer's Disease)
01/2020 - 01/2012
11Neuroendocrine Tumors (Neuroendocrine Tumor)
11/2021 - 10/2002
10Type 2 Diabetes Mellitus (MODY)
05/2021 - 04/2009
10Insulin Resistance
05/2021 - 04/2009
7Neoplasm Metastasis (Metastasis)
03/2022 - 01/2012
6Coronary Artery Disease (Coronary Atherosclerosis)
02/2022 - 07/2011
6Neurodegenerative Diseases (Neurodegenerative Disease)
01/2021 - 02/2007
5Social Phobia
11/2021 - 08/2015
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2013 - 11/2008
4Prostatic Neoplasms (Prostate Cancer)
03/2022 - 01/2019
4Breast Neoplasms (Breast Cancer)
03/2020 - 12/2012
4Amyloid Plaque
11/2015 - 11/2008
3Amyloidosis
01/2020 - 02/2013
3Familial Primary Pulmonary Hypertension
08/2013 - 11/2011
3Ischemia
07/2011 - 04/2009
2Parkinsonian Disorders (Parkinsonism)
05/2022 - 01/2017
2Hyperinsulinism (Hyperinsulinemia)
05/2021 - 08/2018
2Prediabetic State (Prediabetes)
05/2021 - 08/2018
2Mental Disorders (Mental Disorder)
01/2019 - 01/2016
2Dementia (Dementias)
01/2018 - 08/2016
2Diabetic Cardiomyopathies
10/2013 - 10/2009
2Lung Neoplasms (Lung Cancer)
08/2013 - 07/2011
2Thyroid Neoplasms (Thyroid Cancer)
07/2007 - 08/2006
1Hypoxia (Hypoxemia)
06/2022
1COVID-19
06/2022
1Mood Disorders (Mood Disorder)
11/2021
1Inflammation (Inflammations)
01/2021
1Morbid Obesity
01/2021
1Carotid Stenosis (Carotid Artery Stenosis)
01/2021
1Neuroinflammatory Diseases
01/2021
1Hemorrhage
01/2021
1Hyperaldosteronism (Conn Syndrome)
01/2021
1Anxiety Disorders (Anxiety Disorder)
01/2021

Drug/Important Bio-Agent (IBA)

13Glucose (Dextrose)FDA LinkGeneric
05/2021 - 04/2009
7Radioisotopes (Radionuclides)IBA
11/2021 - 02/2002
6Somatostatin Receptors (Somatostatin Receptor)IBA
11/2021 - 01/2013
6Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2016 - 02/2007
5Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
11/2021 - 10/2002
5Peptide Receptors (Peptide Receptor)IBA
11/2021 - 02/2015
5Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
03/2021 - 10/2009
4Ga(III)-DOTATOCIBA
11/2021 - 10/2013
4Serotonin (5 Hydroxytryptamine)IBA
11/2021 - 08/2015
4lutetium Lu 177 dotatateIBA
02/2021 - 02/2015
46- ((3- fluoro- 2- hydroxy)propoxy)- 2- (4- methylaminophenyl)quinolineIBA
01/2021 - 08/2016
4ErbB Receptors (EGF Receptor)IBA
03/2020 - 01/2013
42- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA
01/2020 - 02/2013
4Pharmaceutical PreparationsIBA
08/2015 - 07/2011
4Docetaxel (Taxotere)FDA Link
08/2013 - 10/2010
4Oxygen (Dioxygen)IBA
08/2013 - 11/2011
4Verapamil (Calan)FDA LinkGeneric
10/2012 - 01/2008
3gallium 68 PSMA-11IBA
03/2022 - 01/2019
3Peptides (Polypeptides)IBA
11/2021 - 01/2016
3Proteins (Proteins, Gene)FDA Link
01/2021 - 11/2014
3flutemetamolIBA
01/2020 - 11/2015
3gallium Ga 68 dotatateIBA
01/2020 - 10/2013
3Insulin (Novolin)FDA Link
01/2018 - 10/2009
3Amyloid (Amyloid Fibrils)IBA
02/2016 - 01/2012
3Angiogenesis InhibitorsIBA
01/2012 - 11/2010
3Triglycerides (Triacylglycerol)IBA
11/2010 - 04/2009
2N- (3- iodoprop- 2- enyl)- 2- beta- carbomethoxy- 3- (4- methylphenyl)nortropaneIBA
05/2022 - 01/2017
2Adenosine (Adenocard)FDA LinkGeneric
02/2022 - 12/2017
2Dopamine (Intropin)FDA LinkGeneric
11/2021 - 01/2021
2Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2019
2(R)- (11C)1- (2- chlorophenyl)- N- methyl- N- (1- methylpropyl)- 3- isoquinolinecarboxamideIBA
01/2021 - 12/2009
2LipidsIBA
01/2021 - 12/2019
268Ga-ABY-025IBA
03/2020 - 01/2016
2ABY-025IBA
03/2020 - 01/2016
2Acetates (Acetic Acid Esters)FDA Link
01/2020 - 01/2020
2Prealbumin (Transthyretin)IBA
01/2020 - 02/2013
2Tryptophan (L-Tryptophan)FDA Link
01/2020 - 01/2017
2Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA
01/2020 - 02/2013
2Fatty Acids (Saturated Fatty Acids)IBA
12/2019 - 11/2010
2Amyloid beta-PeptidesIBA
08/2016 - 10/2012
2CarbonIBA
02/2016 - 10/2009
2Anticonvulsants (Antiepileptic Drugs)IBA
01/2016 - 01/2008
2Exenatide (Byetta)FDA Link
01/2015 - 01/2015
2Metformin (Glucophage)FDA LinkGeneric
10/2013 - 04/2009
2Pioglitazone (Actos)FDA Link
10/2013 - 04/2009
2Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2013 - 01/2011
2CalciumIBA
04/2012 - 04/2012
2Bevacizumab (Avastin)FDA Link
01/2012 - 01/2011
2DobutamineFDA LinkGeneric
07/2011 - 04/2009
2Phosphates (Orthophosphate)IBA
10/2009 - 04/2009
1Leukocyte Elastase (Neutrophil Elastase)IBA
06/2022
1FluoridesIBA
03/2022
1GalliumIBA
03/2022
1regadenosonFDA Link
02/2022
1Octreotide (Sandostatin)FDA LinkGeneric
11/2021
1Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
11/2021
1metomidateIBA
01/2021
1EstersIBA
01/2021
1EtomidateFDA LinkGeneric
01/2021
1Hormones (Hormone)IBA
01/2021
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2021

Therapy/Procedure

22Therapeutics
11/2021 - 02/2002
4Drug Therapy (Chemotherapy)
08/2013 - 01/2012
3Radiotherapy
01/2020 - 01/2015
2Glycemic Control
01/2021 - 04/2009
1Gastric Bypass (Roux-en-Y Gastric Bypass)
01/2021